Abstract

Overexpression of protein kinase C delta (PKCdelta) stimulates apoptosis in a wide variety of cell types through a mechanism that is incompletely understood. PKCdelta-deficient cells are impaired in their response to DNA damage-induced apoptosis, suggesting that PKCdelta is required to mount an appropriate apoptotic response under conditions of stress. The mechanism through which it does so remains elusive. In addition to effects on cell survival, PKCdelta elicits pleiotropic effects on cellular proliferation. We now provide the first evidence that the ability of PKCdelta to stimulate apoptosis is intimately linked to its ability to stimulate G(1) phase cell cycle progression. Using an adenoviral-based expression system to express PKCalpha,-delta, and -epsilon in epithelial cells, we demonstrate that a modest increase in PKCdelta activity selectively stimulates quiescent cells to initiate G(1) phase cell cycle progression. Rather than completing the cell cycle, PKCdelta-infected cells arrest in S phase, an event that triggers caspase-dependent apoptotic cell death. Apoptosis was preceded by the activation of cell cycle checkpoints, culminating in the phosphorylation of Chk-1 and p53. Strikingly, blockade of S phase entry using the phosphatidylinositol 3-kinase inhibitor LY294002 prevented checkpoint activation and apoptosis. In contrast, inhibitors of mitogen-activated protein kinase cascades failed to prevent apoptosis. These findings demonstrate that the biological effects of PKCdelta can be extended to include positive regulation of G(1) phase cell cycle progression. Importantly, they reveal the existence of a novel, cell cycle-dependent mechanism through which PKCdelta stimulates cell death.

Highlights

  • National Institutes of Health (NIH) and Grant CA-109543 from NCI, NIH

  • Because PDK-1 is downstream of Phosphatidylinositol 3-kinase (PI3K), we considered the possibility that LY294002 inhibited Protein kinase C (PKC)␦ kinase activity

  • Rather than completing the cell cycle, protein kinase C ␦ (PKC␦)expressing cells arrested in S phase, and perished by caspasedependent apoptosis

Read more

Summary

Introduction

National Institutes of Health (NIH) and Grant CA-109543 from NCI, NIH Pharmacological inhibitors have been used to assess the roles of individual PKC isozymes. We selected thyroid epithelial cells for this analysis because alterations in PKC activity, expression, and structure [5,6,7,8,9] have been documented in human thyroid tumors. The results of this analysis revealed the existence of a novel mechanism through which PKC␦ stimulates apoptosis and demonstrate a tight linkage between the effects of PKC␦ on cell proliferation and cell death

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call